108 related articles for article (PubMed ID: 7014296)
1. Potency test of inactivated polio vaccines in guinea pigs.
Lapinleimu K; Stenvik M
Dev Biol Stand; 1981; 47():109-12. PubMed ID: 7014296
[TBL] [Abstract][Full Text] [Related]
2. Antigenic potency of inactivated poliovirus vaccines.
Moynihan M; Petersen I
Dev Biol Stand; 1981; 47():129-33. PubMed ID: 6262143
[TBL] [Abstract][Full Text] [Related]
3. Potency testing of killed polio vaccine in rats.
van Steenis G; van Wezel AL; Sekhuis VM
Dev Biol Stand; 1981; 47():119-28. PubMed ID: 6262142
[TBL] [Abstract][Full Text] [Related]
4. A WHO collaborative study of immunogenicity assays of inactivated poliovirus vaccines.
Wood DJ; Heath AB
Biologicals; 1995 Dec; 23(4):301-11. PubMed ID: 8825859
[TBL] [Abstract][Full Text] [Related]
5. Formation of autoantibodies in laboratory animals after inoculation of viruses with different virulence. I. Results of studies on vaccine and wild strains of polio and measles viruses in guinea pigs.
Grachev VP; Popova VD; Vasilyeva IG; Avdeyeva LI
Acta Virol; 1973 Jul; 17(4):319-26. PubMed ID: 4148212
[No Abstract] [Full Text] [Related]
6. Validation of the toxin-binding inhibition (ToBI) test for the estimation of the potency of the tetanus toxoïd component in vaccines.
van der Gun J; Akkermans A; Hendriksen C; van de Donk H
Dev Biol Stand; 1996; 86():199-206. PubMed ID: 8785949
[TBL] [Abstract][Full Text] [Related]
7. New approach to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines.
van Wezel AL; van Steenis G; Hannik CA; Cohen H
Dev Biol Stand; 1978; 41():159-68. PubMed ID: 223908
[TBL] [Abstract][Full Text] [Related]
8. Proposals on the control of VERO cells used to prepare inactivated poliomyelitis vaccine.
Ménetrat JL; Chaniot S; Lefrançois S; Canale A; Chippaux A
Dev Biol Stand; 1981; 47():163-7. PubMed ID: 6785125
[TBL] [Abstract][Full Text] [Related]
9. Potency test of killed polio vaccines. Statistical analysis of test on chicken and preliminary results in combination with ELISA D-antigen determinations.
Larbaigt G; Moulin J; Souvras M; Gibelin N; Beranger G
Dev Biol Stand; 1981; 47():113-8. PubMed ID: 6262141
[TBL] [Abstract][Full Text] [Related]
10. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
Gupta RK; Siber GR
Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
[TBL] [Abstract][Full Text] [Related]
11. Swedish inactivated polio vaccine: laboratory standardization and clinical experience over a 30-year period.
Böttiger M; Larsson B
Biologicals; 1992 Dec; 20(4):267-75. PubMed ID: 1305403
[TBL] [Abstract][Full Text] [Related]
12. A note on single- and two-dose immunogenicity tests of inactive virus vaccine in chicks.
Slonim D; Drevo M
J Hyg Epidemiol Microbiol Immunol; 1976; 21(3):368-70. PubMed ID: 1033226
[TBL] [Abstract][Full Text] [Related]
13. The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines.
Krämer B; Schildger H; Behrensdorf-Nicol HA; Hanschmann KM; Duchow K
Biologicals; 2009 Apr; 37(2):119-26. PubMed ID: 19181541
[TBL] [Abstract][Full Text] [Related]
14. Mutual interactions between DTaP-IPV and Haemophilus influenzae type b (Hib)-conjugated vaccines in laboratory animal models.
Shams H; Heron I
Biologicals; 1999 Sep; 27(3):227-40. PubMed ID: 10652178
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine.
Gupta RK; Anderson R; Cecchini D; Rost B; Xu J; Gendreau K; Saroff DL; Marchant C; Siber GR
Biologicals; 1999 Jun; 27(2):167-76. PubMed ID: 10600208
[TBL] [Abstract][Full Text] [Related]
16. Comparison of sensitivity of VERO cell line versus primary monkey kidney cells in the detection of residual live polio virus during and after inactivation.
Montagnon BJ; Nicolas AJ; Fanget B; Peyron L
Dev Biol Stand; 1981; 47():151-5. PubMed ID: 6262146
[TBL] [Abstract][Full Text] [Related]
17. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T
Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173
[TBL] [Abstract][Full Text] [Related]
18. Development of a guinea-pig model for potency/immunogenicity evaluation of diphtheria, tetanus acellular pertussis (DTaP) and Haemophilus influenzae type b polysaccharide conjugate vaccines.
Gupta RK; Anderson R; Cecchini D; Rost B; Griffin P; Benscoter K; Xu J; Montanez-Ortiz L; Siber GR
Dev Biol Stand; 1996; 86():283-96. PubMed ID: 8785957
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study.
Halperin SA; McDonald J; Samson L; Danzig L; Santos G; Izu A; Smith B; MacDonald N
Clin Invest Med; 2002 Dec; 25(6):243-51. PubMed ID: 12516995
[TBL] [Abstract][Full Text] [Related]
20. [Test of the potency of trivalent oral polio vaccines: comparison of 2 methods of reading].
Chocarro LB; Manau MV
Rev Argent Microbiol; 1987; 19(2):65-9. PubMed ID: 2459727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
